A real-world study on prevalence of and outcomes related to brain metastases among patients with HER2-positive metastatic breast cancer (mBC)

被引：0
|
作者：
Collins, J. [1 ]
Varghese, D. [2 ]
Miranda, M. [3 ]
Nordstrom, B. [4 ]
Murphy, B. [5 ]
Harland, D. [6 ]
机构：
[1] Evidera Waltham, Res, Waltham, MA USA
[2] AstraZeneca, Real World Evidence Generat & Epidemiol, Gaithersburg, MD USA
[3] AstraZeneca, Stat, Cambridge, England
[4] Evidera Waltham, Epidemol, Real World Evidence, Waltham, MA USA
[5] Evidera Waltham, Stat, Waltham, MA USA
[6] AstraZeneca, Global Med Affairs, Cambridge, England
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.03.205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
186P
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes and safety of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients: A prospective cohort study
    Luo, T.
    Zhang, Q.
    He, P.
    Zhong, X.
    Yan, X.
    Tian, T.
    Huang, J.
    Zhang, Z.
    Zheng, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S490 - S490
  • [2] Real-world outcomes among patients with HER2+metastatic breast cancer with brain metastases
    DeBusk, Kendra
    Ike, Chiemeka
    Lindegger, Nicolas
    Schwartz, Naomi
    Surinach, Andy
    Liu, Yutong
    Forero-Torres, Andres
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 657 - 666
  • [3] Real-world outcomes among HER2+metastatic breast cancer patients with brain metastases
    Lindegger, N.
    Ike, C.
    Schwartz, N. R. M.
    Surinach, A.
    Liu, Y.
    Forero-Torres, A.
    DeBusk, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S365 - S366
  • [4] A real-world evidence study of treatment patterns among patients with HER2-positive metastatic breast cancer
    Collins, Jenna
    Nordstrom, Beth
    Kwong, Jackie
    Murphy, Brian
    Pavilack, Melissa
    CANCER RESEARCH, 2021, 81 (04)
  • [5] Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study
    Sanglier, Thibaut
    Shim, Jinjoo
    Lamarre, Neil
    Pena-Murillo, Claudia
    Antao, Vincent
    Montemurro, Filippo
    BREAST, 2023, 69 : 441 - 450
  • [6] Real World Data for Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases
    Toler, Andrew
    Bobolts, Laura R.
    Mangurian, Mark
    Pozotrigo, Melissa
    Wise, Corey
    Solomon, Hiywete
    Hartung, Nicole
    Makielski, Rory
    Marur, Shika
    Ravindranathan, Meera
    Marur, Shanthi
    CANCER RESEARCH, 2023, 83 (05)
  • [7] Real-world survival of Danish patients with HER2-positive metastatic breast cancer
    Artzi, Daniel
    Berg, Tobias
    Celik, Alan
    Kumler, Iben
    Kenholm, Julia
    Al-Rawi, Sami
    Jensen, Maj-Britt
    Andersson, Michael
    Knoop, Ann
    ACTA ONCOLOGICA, 2023, 62 (06) : 601 - 607
  • [8] Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
    Zhang, Qiongwen
    He, Ping
    Tian, Tinglun
    Yan, Xi
    Huang, Juan
    Zhang, Zhang
    Zheng, Hong
    Zhong, Xiaorong
    Luo, Ting
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Outcomes of real-world use of eribulin plus trastuzumab for HER2-positive metastatic breast cancer
    Mougalian, S. S.
    Copher, R.
    McAllister, L.
    Radtchenko, J.
    Wang, E. C.
    Broscious, M.
    Yu, H-T
    Kish, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Efficacy of lapatinib combined with capecitabine in patients with HER2-positive metastatic breast cancer in a real-world study
    Gui, Xinyu
    Li, Huiping
    Yan, Ying
    Zhang, Ruyan
    ONCOLOGY LETTERS, 2020, 20 (06)
12345